Compare Gema Grahasarana Tbk. (GEMA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gema Grahasarana Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Gema Grahasarana Tbk. trades at Rp80 (market cap 129.6B, 384.5K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 5× Gema Grahasarana Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (848.2K versus 384.5K). Which is the better fit depends on your goals.
| GEMA | LABS | |
|---|---|---|
Market Cap | 129.6B | 651.75B |
Volume | 384.5K | 848.2K |
Lot | 3.85K | 8.48K |
Turnover | 31.01M | 140.51M |
Average Price | 80.66 | 165.66 |
Value | 31.01M | 140.51M |
Indicative Equilibrium Price | 80 | 168 |
Indicative Equilibrium Volume | 10 | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gema Grahasarana Tbk.
PT Gema Grahasarana Tbk formerly PT Gema Gerhana Sarana (The Company) was established on December 7th 1984 in Jakarta. The corporate is a member of Vinoti business. The core business is in manufacture, trade and services of interior & furniture. Corporate have 2 subsidiaries: 1. LKS which conduct in industry, trade & service of panel component of furniture & interior. 2. PGM which conduct in industry, trade & construction service of mechanical, electrical for industrial, commercial & industrial.
Read more on GEMA →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
